Dividendos de Ortin Laboratories

Dividendo controles de criterios 0/6

Ortin Laboratories no paga actualmente dividendo.

Información clave

Rentabilidad por dividendo

Ratio de pago

Rentabilidad media de la industria	0.8%
Próxima fecha de pago de dividendos	n/a
Fecha ex dividendo	n/a
Dividendo por acción	n/a
Beneficios por acción	-₹5.04
Rentabilidad por dividendo prevista a 3 años	n/a

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

Here's Why I Think Ortin Laboratories (NSE:ORTINLABSS) Might Deserve Your Attention Today

Jan 24

Is Ortin Laboratories (NSE:ORTINLABSS) A Risky Investment?

Dec 27

Ortin Laboratories Limited (NSE:ORTINLABSS) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Nov 30

Here's Why Ortin Laboratories (NSE:ORTINLABSS) Is Weighed Down By Its Debt Load

Sep 15

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de ORTINLAB han sido estables en el pasado.

Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de ORTINLAB han aumentado.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Ortin Laboratories vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de ORTINLAB con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (ORTINLAB)	0%
Suelo de mercado 25% (IN)	0.3%
Techo de mercado 25% (IN)	1.2%
Media de la industria (Pharmaceuticals)	0.8%
Previsión de analistas en 3 años (ORTINLAB)	n/a

Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de ORTINLAB en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Alto dividendo: No es posible evaluar la rentabilidad por dividendo de ORTINLAB en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Pago de beneficios a los accionistas

Cobertura de los beneficios: ORTINLAB no paga un dividendo notable para el mercado Indian.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que ORTINLAB no ha comunicado ningún pago.

Dividendos de Ortin Laboratories

Dividendo controles de criterios 0/6

Información clave

Últimas actualizaciones de dividendos

Recent updates

Third quarter 2024 earnings released: ₹3.43 loss per share (vs ₹0.56 profit in 3Q 2023)

Ortin Laboratories Limited Appoints Divya Purswani as Company Secretary and Compliance Officer

Ortin Laboratories Limited to Report Q3, 2024 Results on Feb 13, 2024

Now 22% overvalued after recent price rise

Insufficient new directors

Second quarter 2024 earnings released

Ortin Laboratories Limited Announces Executive Changes

Ortin Laboratories Limited Appointment of Harish Sharma as Company Secretary

Ortin Laboratories Limited, Annual General Meeting, Sep 30, 2023

First quarter 2024 earnings released

Ortin Laboratories Limited to Report Q1, 2024 Results on Aug 14, 2023

Drugs Control Administration, Government of Telangana Cancels Manufacturing License of Ortin Laboratories Limited

Ortin Laboratories Limited Announces Resignation of Nitesh Kumar Sharma as Company Secretary/Compliance Officer

New minor risk - Share price stability

Full year 2023 earnings released: ₹0.08 loss per share (vs ₹0.49 loss in FY 2022)

Third quarter 2023 earnings released: EPS: ₹0.56 (vs ₹0.11 loss in 3Q 2022)

Ortin Laboratories Limited to Report Q3, 2023 Results on Feb 14, 2023

Ortin Laboratories Limited Announces Resignation of J R K Panduranga Rao as Independent Director

Second quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.07 in 2Q 2022)

Ortin Laboratories Limited to Report First Half, 2023 Results on Nov 14, 2022

Ortin Laboratories Limited Announces Cessation of Bh. Satyanarayana Raju and G. Venkata Ramana, Directors

Ortin Laboratories Limited, Annual General Meeting, Sep 30, 2022

First quarter 2023 earnings released: ₹0.05 loss per share (vs ₹0.11 profit in 1Q 2022)

Ortin Laboratories Limited to Report Q1, 2023 Results on Aug 13, 2022

Full year 2022 earnings released: ₹0.49 loss per share (vs ₹1.16 profit in FY 2021)

Ortin Laboratories Limited to Report Q4, 2022 Results on May 30, 2022

Whole Time Director Sanka Mohan Murthy has left the company

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹1.16 (vs ₹0.69 loss in FY 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Ortin Laboratories Limited to Report Q3, 2021 Results on Feb 13, 2021

Here's Why I Think Ortin Laboratories (NSE:ORTINLABSS) Might Deserve Your Attention Today

Investor sentiment improved over the past week

Ortin Laboratories Limited Appoints Mr. S. Srinivas Kumar as CFO

Investor sentiment improved over the past week

New 90-day high: ₹30.00

Is Ortin Laboratories (NSE:ORTINLABSS) A Risky Investment?

Ortin Laboratories Limited Appoints Pottur Sujatha as Additional Director

Market bids up stock over the past week

Ortin Laboratories Limited (NSE:ORTINLABSS) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

New 90-day high: ₹23.15

First quarter earnings released

Here's Why Ortin Laboratories (NSE:ORTINLABSS) Is Weighed Down By Its Debt Load

Ortin Laboratories Limited to Report Q1, 2021 Results on Sep 15, 2020

Ortin Laboratories Limited to Report Q4, 2020 Results on Jul 30, 2020

Estabilidad y crecimiento de los pagos

Rentabilidad por dividendo vs. Mercado

Pago de beneficios a los accionistas

Pago en efectivo a los accionistas

Discover strong dividend paying companies